Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02977104 · ClinicalTrials.gov registry record · NA

Maestro Handheld Cardiac Monitor Validation

A NA study of Cardiac Arrhythmia, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT02977104 is a NA study of Cardiac Arrhythmia that has completed, run by University of Michigan. The registered enrollment target is 70 participants, below the 208-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02977104, a NA study of Cardiac Arrhythmia, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to demonstrate that the Maestro hand held heart monitor can accurately diagnose Atrial Fibrillation, atrial flutter or normal sinus rhythm in patients.

Conditions Studied

Interventions

  • OTHER Maestro ECG

Study Locations (1)

Michigan

  • University of Michigan Cardiovascular Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2013-07-01
Est. Completion 2017-12-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT02977104

The ClinicalTrials.gov registry entry for NCT02977104 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 208-participant average among 12 other Cardiac Arrhythmia trials with a reported enrollment target (66% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiac Arrhythmia appearing as the primary indexed condition, and to 1 intervention - of which Maestro ECG is the first listed.

NCT02977104 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02977104 about?

NCT02977104 is a clinical study titled "Maestro Handheld Cardiac Monitor Validation". The purpose of this study is to demonstrate that the Maestro hand held heart monitor can accurately diagnose Atrial Fibrillation, atrial flutter or normal sinus rhythm in patients.

What is the current status of trial NCT02977104?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-07-01. Estimated completion is 2017-12-05.

What conditions does trial NCT02977104 study?

This clinical trial studies the following conditions: Cardiac Arrhythmia.

What interventions are being tested in trial NCT02977104?

The interventions under investigation include: Maestro ECG (OTHER).

Who is sponsoring clinical trial NCT02977104?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02977104 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiac Arrhythmia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.